ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALLK Allakos Inc

1.09
0.03 (2.83%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Allakos Inc ALLK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.03 2.83% 1.09 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.05 1.05 1.10 1.05 1.06
more quote information »

Recent News

Date Time Source Heading
15/3/202407:02GLOBEAllakos Provides Business Update and Reports Fourth Quarter..
07/3/202410:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202410:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:22EDGAR2Form 144 - Report of proposed sale of securities
05/3/202409:52EDGAR2Form 144 - Report of proposed sale of securities
26/2/202423:05EDGAR2Form 8-K - Current report
26/2/202423:02GLOBEAllakos Presents Preclinical Data Highlighting Inhibition of..
22/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202411:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/2/202408:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202400:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:07EDGAR2Form 8-K - Current report
12/2/202423:02GLOBEAllakos Announces Publication Highlighting AK006 Mast Cell..
03/2/202408:05EDGAR2Form 8-K - Current report
03/2/202404:31EDGAR2Form SC 13D/A - General statement of acquisition of..
17/1/202409:00EDGAR2Form 8-K - Current report
16/1/202423:02GLOBEAllakos Announces a Restructuring to Focus on Development of..
16/1/202423:00GLOBEAllakos Announces Phase 2 Lirentelimab Trials in Atopic..
06/1/202408:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202307:49EDGAR2Form 144 - Report of proposed sale of securities
05/12/202307:31EDGAR2Form 144 - Report of proposed sale of securities
05/12/202307:21EDGAR2Form 144 - Report of proposed sale of securities
27/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202309:01EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202308:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:10EDGAR2Form 8-K - Current report
14/11/202308:02GLOBEAllakos Provides Business Update and Reports Third Quarter..
08/9/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202306:06EDGAR2Form 144 - Report of proposed sale of securities
06/9/202305:57EDGAR2Form 144 - Report of proposed sale of securities
06/9/202305:52EDGAR2Form 144 - Report of proposed sale of securities
31/8/202307:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202306:05EDGAR2Form 8-K - Current report
31/8/202306:05GLOBEAllakos Appoints Neil Graham to its Board of Directors
22/8/202306:02EDGAR2Form 8-K - Current report
10/8/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:08EDGAR2Form 8-K - Current report
10/8/202306:02GLOBEAllakos Provides Business Update and Reports Second Quarter..
04/8/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202308:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202306:05GLOBEAllakos Appoints Rand Sutherland and Dolca Thomas to its..
03/8/202306:03EDGAR2Form 8-K - Current report
12/6/202321:02GLOBEAllakos Presents Preclinical Data at EAACI Hybrid Congress..

Your Recent History

Delayed Upgrade Clock